Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival

A. Jawhari, S. Jordan, S. Poole, P. Browne, M. Pignatelli, M. J.G. Farthing

Research output: Contribution to journalArticlepeer-review

241 Citations (Scopus)


Background and Aims: The E-cadherin-catenin complex plays a critical role in the maintenance of normal tissue architecture. Mutation of any of its components is believed to result in loss of cell-cell adhesion and contribute to neoplasia. The aim of this study was to examine the expression of E- cadherin and α-, β-, and γ-catenin in gastric carcinoma and dysplasia and determine any relationship with tumor characteristics and survival. Methods: Immunoperoxidase staining of E-cadherin and α-, β-, and γ-catenin was performed using 89 gastric carcinomas, lymph node metastases, and gastric biopsy specimens from 14 patients with dysplasia and 10 healthy controls. Results: Membranous staining was observed in control biopsy specimens for all components of the complex. Up to 57% of gastric dysplasia and 90% of tumors stained abnormally for one or more components of the cadherin-catenin complex. Abnormal E-cadherin and γ-catenin staining occurred more frequently in diffuse than intestinal tumors (P < 0.0005 and < 0.05, respectively). No association with tumor grade or stage was found. A survival advantage was noted in intestinal and diffuse tumors retaining membranous expression of β- catenin, independent of tumor type, grade, or stage (P < 0.005). Conclusions: Abnormal expression of the E-cadherin-catenin complex occurs frequently in gastric carcinoma. The close correlation with poor survival suggests that abnormal β-catenin may be a useful prognostic marker.

Original languageEnglish
Pages (from-to)46-54
Number of pages9
Issue number1
Publication statusPublished - Jan 1 1997

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival'. Together they form a unique fingerprint.

Cite this